Literature DB >> 11558880

Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody.

R Soda, A Costanzo, M Cantonetti, A Orlandi, L Bianchi, S Chimenti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11558880     DOI： 10.1080/000155501750376339

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  1 in total

1.  Rituximab-CHOP induced interstitial pneumonitis in patients with disseminated extranodal marginal zone B cell lymphoma.

Authors:  Kwang Min Kim; Ho-Cheol Kim; Kyung-Nyeo Jeon; Hoon-Gu Kim; Jung Hun Kang; Jong Ryeal Hahm; Gyeong-Won Lee
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.